Latest & greatest articles for aids

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on aids or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on aids and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for aids

361. Guidelines for the fitting, verification and evaluation of digital signal processing hearing aids within a children’s hearing aid service

Guidelines for the fitting, verification and evaluation of digital signal processing hearing aids within a children’s hearing aid service [len:6, cleaned:] ____

Publication 10832006

362. Guidelines for testing digital signal processing hearing aids ‘in the field’ within an integrated children’s hearing aid service

Guidelines for testing digital signal processing hearing aids ‘in the field’ within an integrated children’s hearing aid service [len:6, cleaned:] ____

Publication 10832006

363. Guidelines for the taking of impressions and provision of ear moulds within a children’s hearing aid service

Guidelines for the taking of impressions and provision of ear moulds within a children’s hearing aid service [len:6, cleaned:] ____

Publication 10832006

364. Guidelines for professional links between audiology and education services within a children’s hearing aid service

Guidelines for professional links between audiology and education services within a children’s hearing aid service [len:6, cleaned:] ____

Publication 10832006

365. Setting and organization of care for persons living with HIV/AIDS.

Setting and organization of care for persons living with HIV/AIDS. BACKGROUND: Treating the world's 40.3 million persons currently infected with HIV/AIDS is an international responsibility that involves unprecedented organizational challenges. Key issues include whether care should be concentrated or decentralized, what type and mix of health workers are needed, and which interventions and mix of programs are best. High volume centres, case management and multi-disciplinary care have been shown (...) to be effective for some chronic illnesses. Application of these findings to HIV/AIDS is less well understood. OBJECTIVES: Our objective was to evaluate the association between the setting and organization of care and outcomes for people living with HIV/AIDS. SEARCH STRATEGY: Computerized searches from January 1, 1980 to December 31, 2002 of MEDLINE, EMBASE, Dissertation Abstracts International (DAI), CINAHL, HealthStar, PsychInfo, PsychLit, Social Sciences Abstracts, and Sociological Abstracts as well

Cochrane2006

366. A prognostic index for AIDS-associated Kaposi's sarcoma in the era of highly active antiretroviral therapy.

A prognostic index for AIDS-associated Kaposi's sarcoma in the era of highly active antiretroviral therapy. BACKGROUND: AIDS-associated Kaposi's sarcoma remains common in individuals with HIV-1 infection in the era of highly active antiretroviral therapy (HAART). We developed a simple model for predicting mortality on the basis of clinical characteristics present at the time of diagnosis of Kaposi's sarcoma. METHODS: Of 5873 individuals with HIV-1 infection, 326 (6%) developed Kaposi's sarcoma (...) ; for 262 (80%) this was their first AIDS-defining illness. We did univariate and multivariate Cox regression analyses to identify covariates predictive of overall survival and validated our model with an independent data set of 446 patients with Kaposi's sarcoma. RESULTS: In the primary model, we developed a prognostic score from 0 to 15 starting at 10. Having Kaposi's sarcoma as the AIDS-defining illness (-3 points) and increasing CD4 count (-1 point for every complete 100 cells per mm3) improved

Lancet2006

367. Stavudine, lamivudine and nevirapine combination therapy for treatment of HIV infection and AIDS in adults.

Stavudine, lamivudine and nevirapine combination therapy for treatment of HIV infection and AIDS in adults. BACKGROUND: A favourable regimen for people infected with HIV/AIDS is one that provides optimal efficacy, durability of antiretroviral activity, tolerability, and has low adverse effects and drug-drug interactions. The combination of the non-nucleoside reverse transcriptase inhibitor nevirapine (NVP), and two nucleoside reverse transcriptase inhibitors, stavudine (d4T) and lamivudine (3TC (...) ), is widely used as first-line therapy, especially in low-resource countries. Analysis of the efficacy, durability and tolerability of the regimen is thus important to clinicians, consumers and policy-makers living in both rich and poor countries. OBJECTIVES: To examine the efficacy of the stavudine, lamivudine and nevirapine regimen for the treatment of HIV infection and AIDS in adults. SEARCH STRATEGY: We used the comprehensive search strategy developed specifically by the Cochrane HIV/AIDS Review Group

Cochrane2006

368. Anxiety disorders in patients with HIV/AIDS. Mental health care for people with HIV infection.

Anxiety disorders in patients with HIV/AIDS. Mental health care for people with HIV infection. Anxiety disorders in patients with HIV/AIDS. Mental health care for people with HIV infection. | National Guideline Clearinghouse Search Sign In Username or Email * Password * Remember Me Don't have an account? Guideline Summary NGC:004888 This guideline summary has been withdrawn from NGC. Please update your bookmarks. View all withdrawn summaries in the . About NGC Guideline Summaries NGC's

New York State Department of Health2006

369. Effects of a web based decision aid on parental attitudes to MMR vaccination: a before and after study.

Effects of a web based decision aid on parental attitudes to MMR vaccination: a before and after study. OBJECTIVE: To determine whether an evidence based decision aid on the measles, mumps, and rubella (MMR) vaccine changed parents' attitudes towards vaccination. DESIGN: Before and after study. SETTING: Website promoted through search engines and online parenting and health websites. PARTICIPANTS: 158 people completing online questions out of 1277 who accessed the website. INTERVENTION (...) : Evidence based decision aid with text and graphical representation of the possible outcomes of measles, mumps, and rubella diseases compared with MMR vaccination. MAIN OUTCOME MEASURES: Attitudes towards MMR vaccination. RESULTS: Significantly more participants indicated they were "leaning towards" vaccination after using the decision aid (39% before v 55% after, P < 0.001). Compared with those who were undecided or "leaning away from" vaccination after using the decision aid, participants "leaning

BMJ2006 Full Text: Link to full Text with Trip Pro

370. Personality disorders in patients with HIV/AIDS. Mental health care for people with HIV infection.

Personality disorders in patients with HIV/AIDS. Mental health care for people with HIV infection. Personality disorders in patients with HIV/AIDS. | National Guideline Clearinghouse Search Sign In Username or Email * Password * Remember Me Don't have an account? Guideline Summary NGC:005002 This guideline summary has been withdrawn from NGC. Please update your bookmarks. View all withdrawn summaries in the . About NGC Guideline Summaries NGC's guidelines summaries contain information

New York State Department of Health2006

371. A systematic review of the nonacoustic benefits of bone-anchored hearing aids

A systematic review of the nonacoustic benefits of bone-anchored hearing aids A systematic review of the nonacoustic benefits of bone-anchored hearing aids A systematic review of the nonacoustic benefits of bone-anchored hearing aids Johnson C E, Danhauer J L, Reith A C, Latiolais L N CRD summary This review of the nonacoustic benefits of bone-anchored hearing aids (BAHAs) found limited evidence of increased quality of life following BAHA implantation in comparison with conventional hearing (...) aids or no hearing aids at all. The conclusions reflect the limited evidence available but, given the poor quality of the primary studies and potential methodological weaknesses in the review, the reliability of these conclusions remains unclear. Authors' objectives To review the nonacoustic benefits of bone-anchored hearing aids (BAHAs) in comparison with other forms of amplification. Searching ComDisDome and PubMed were searched; the search terms were reported. The reference lists of all included

DARE.2006

372. Cost-effectiveness analysis comparing chemotherapy regimens in the treatment of AIDS-related Kaposi's sarcoma in Brazil

Cost-effectiveness analysis comparing chemotherapy regimens in the treatment of AIDS-related Kaposi's sarcoma in Brazil Cost-effectiveness analysis comparing chemotherapy regimens in the treatment of AIDS-related Kaposi's sarcoma in Brazil Cost-effectiveness analysis comparing chemotherapy regimens in the treatment of AIDS-related Kaposi's sarcoma in Brazil Vanni T, Lopes Fonseca B A, Polanczyk C A Record Status This is a critical abstract of an economic evaluation that meets the criteria (...) for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn. Health technology The study examined several palliative regimens for Kaposi's sarcoma (KS) related to acquired immunodeficiency syndrome (AIDS). The regimens considered were pegylated liposomal doxorubicin (PLD), liposomal daunorubicin (DNX), and a combination of doxorubicin, bleomycin

NHS Economic Evaluation Database.2006

373. Computer-aided detection of breast cancer: a cost-effectiveness study

Computer-aided detection of breast cancer: a cost-effectiveness study Computer-aided detection of breast cancer: a cost-effectiveness study Computer-aided detection of breast cancer: a cost-effectiveness study Lindfors K K, McGahan M C, Rosenquist C J, Hurlock G S Record Status This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical (...) assessment on the reliability of the study and the conclusions drawn. Health technology The study examined computer-aided detection (CAD) of breast cancer as an add-on to a screening mammography programme. The three strategies compared were mammography, mammography plus CAD, and clinical observation. Type of intervention Screening. Economic study type Cost-effectiveness analysis. Study population The study used three hypothetical groups of women aged between 40 and 79 years. The first group comprised

NHS Economic Evaluation Database.2006

374. Computer-aided detection of malignancy with magnetic resonance imaging of the breast

Computer-aided detection of malignancy with magnetic resonance imaging of the breast Computer-aided detection of malignancy with magnetic resonance imaging of the breast Computer-aided detection of malignancy with magnetic resonance imaging of the breast BlueCross BlueShield Association Record Status This is a bibliographic record of a published health technology assessment. No evaluation of the quality of this assessment has been made for the HTA database. The BlueCross BlueShield Association (...) Technology Evaluation Center website ( ) includes the most recent 3 years of TEC Assessments. To request older reports, please use the “contact us” feature on the website. Citation BlueCross BlueShield Association. Computer-aided detection of malignancy with magnetic resonance imaging of the breast. Chicago: BlueCross BlueShield Association (BCBS). TEC Assessment 21(4). 2006 Authors' objectives The aim of this review was to assess the evidence on the use of computer-aided detection (CAD) with magnetic

Health Technology Assessment (HTA) Database.2006

375. Bone-anchored hearing aids

Bone-anchored hearing aids Bone-anchored hearing aids Bone-anchored hearing aids Bergeron F Record Status This is a bibliographic record of a published health technology assessment from a member of INAHTA. No evaluation of the quality of this assessment has been made for the HTA database. Citation Bergeron F. Bone-anchored hearing aids. Montreal: Agence d'evaluation des technologies et des modes d'intervention en sante (AETMIS). AETMIS 06-05. 2006 Authors' objectives This report reviews (...) the current evidence on bone-anchored hearing aids (BAHA). Authors' conclusions Available information shows, in a limited way, the effectiveness of bone-anchored hearing aids. For the usual applications for users of bone-conduction hearing aids and for wearers of conventional hearing aids who present with chronic middle-ear infections, they have gone beyond the experimental stage and may be classified as innovative. This development status nevertheless restricts the implantation of these hearing aids to

Health Technology Assessment (HTA) Database.2006

376. Computer-aided detection with full-field digital mammography

Computer-aided detection with full-field digital mammography Computer-aided detection with full-field digital mammography Computer-aided detection with full-field digital mammography BlueCross BlueShield Association Record Status This is a bibliographic record of a published health technology assessment. No evaluation of the quality of this assessment has been made for the HTA database. The BlueCross BlueShield Association Technology Evaluation Center website ( ) includes the most recent 3 (...) years of TEC Assessments. To request older reports, please use the “contact us” feature on the website. Citation BlueCross BlueShield Association. Computer-aided detection with full-field digital mammography. Chicago: BlueCross BlueShield Association (BCBS). TEC Assessment 21(3). 2006 Authors' objectives The objective of this assessment is to evaluate the impact of using computer-aided detection (CAD) vs. single reading on the sensitivity, specificity, and biopsy rates for full-field digital

Health Technology Assessment (HTA) Database.2006

377. Visual mobility aids for patients with night blindness

Visual mobility aids for patients with night blindness Visual mobility aids for patients with night blindness Visual mobility aids for patients with night blindness Martin V Record Status This is a bibliographic record of a published health technology assessment from a member of INAHTA. No evaluation of the quality of this assessment has been made for the HTA database. Citation Martin V. Visual mobility aids for patients with night blindness. Montreal: Agence d'evaluation des technologies et

Health Technology Assessment (HTA) Database.2006

378. Cost effectiveness analysis of strategies to combat HIV/AIDS in developing countries.

Cost effectiveness analysis of strategies to combat HIV/AIDS in developing countries. OBJECTIVE: To assess the costs and health effects of a range of interventions for preventing the spread of HIV and for treating people with HIV/AIDS in the context of the millennium development goal for combating HIV/AIDS. DESIGN: Cost effectiveness analysis based on an epidemiological model. SETTING: Analyses undertaken for two regions classified using the WHO epidemiological grouping-Afr-E, countries in sub

BMJ2005 Full Text: Link to full Text with Trip Pro

379. Antiretroviral therapy in a thousand patients with AIDS in Haiti.

Antiretroviral therapy in a thousand patients with AIDS in Haiti. BACKGROUND: The one-year survival rate of adults and children with the acquired immunodeficiency syndrome (AIDS), without antiretroviral therapy, has been about 30 percent in Haiti. Antiretroviral therapy has recently become available in Haiti and in other developing countries. Data on the efficacy of antiretroviral therapy in developing countries are limited. High rates of coinfection with tropical diseases and tuberculosis (...) , along with malnutrition and limited laboratory monitoring of therapy, may decrease the efficacy of antiretroviral therapy in these countries. METHODS: We studied the efficacy of antiretroviral therapy in the first 1004 consecutive patients with AIDS and without previous antiretroviral therapy who were treated beginning in March 2003 in Port-au-Prince, Haiti. RESULTS: During a 14-month period, three-drug antiretroviral therapy was initiated in 1004 patients, including 94 children under 13 years

NEJM2005

380. A prognostic index for systemic AIDS-related non-Hodgkin lymphoma treated in the era of highly active antiretroviral therapy.

A prognostic index for systemic AIDS-related non-Hodgkin lymphoma treated in the era of highly active antiretroviral therapy. BACKGROUND: The established International Prognostic Index for lymphomas has not included patients with systemic AIDS-related non-Hodgkin lymphoma. OBJECTIVE: To establish the most appropriate prognostic index for use in patients with systemic AIDS-related non-Hodgkin lymphoma. DESIGN: A prospective study involving univariate and multivariable analyses of patients (...) with AIDS-related non-Hodgkin lymphoma whose data were used to examine standard and new criteria for survival after diagnosis. SETTING: The Chelsea and Westminster cohort of HIV-1-infected persons. PATIENTS: 9621 HIV-positive patients, 111 in whom AIDS-related non-Hodgkin lymphoma was treated after 1996, in the era of highly active antiretroviral therapy (HAART). INTERVENTION: Cox proportional hazards regression analysis to determine the prognostic significance of multiple clinicopathologic variables

Annals of Internal Medicine2005